Bagiński M[Author] - Search Results

Year	Number of Results
1976	1
1989	1
1994	1
1997	3
2000	1
2002	3
2004	1
2005	4
2006	3
2007	1
2009	3
2010	1
2013	1
2014	3
2015	3
2016	3
2017	5
2018	7
2019	5
2020	7
2021	7
2022	12
2023	5
2024	1

1

In silico design of telomerase inhibitors.

Baginski M, Serbakowska K. Baginski M, et al. Drug Discov Today. 2020 Jul;25(7):1213-1222. doi: 10.1016/j.drudis.2020.04.024. Epub 2020 May 6. Drug Discov Today. 2020. PMID: 32387261 Free article. Review.

2

Cancer immune escape: the role of antigen presentation machinery.

Kallingal A, Olszewski M, Maciejewska N, Brankiewicz W, Baginski M. Kallingal A, et al. Among authors: baginski m. J Cancer Res Clin Oncol. 2023 Aug;149(10):8131-8141. doi: 10.1007/s00432-023-04737-8. Epub 2023 Apr 9. J Cancer Res Clin Oncol. 2023. PMID: 37031434 Free PMC article. Review.

3

STEM Tomography of Au Helical Assemblies.

Sobczak K, Turczyniak-Surdacka S, Lewandowski W, Baginski M, Tupikowska M, González-Rubio G, Wójcik M, Carlsson A, Donten M. Sobczak K, et al. Among authors: baginski m. Microsc Microanal. 2021 Jun 25:1-5. doi: 10.1017/S1431927621012009. Online ahead of print. Microsc Microanal. 2021. PMID: 34169809

4

Amphotericin B and its new derivatives - mode of action.

Baginski M, Czub J. Baginski M, et al. Curr Drug Metab. 2009 Jun;10(5):459-69. doi: 10.2174/138920009788898019. Curr Drug Metab. 2009. PMID: 19689243 Review.

5

Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic.

Baginski M, Sternal K, Czub J, Borowski E. Baginski M, et al. Acta Biochim Pol. 2005;52(3):655-8. Epub 2005 Aug 5. Acta Biochim Pol. 2005. PMID: 16086075 Free article. Review.

6

Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies.

Baginski M, Czub J, Sternal K. Baginski M, et al. Chem Rec. 2006;6(6):320-32. doi: 10.1002/tcr.20096. Chem Rec. 2006. PMID: 17304519 Review.

7

Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres.

Maciejewska N, Olszewski M, Jurasz J, Baginski M, Stasevych M, Zvarych V, Folini M, Zaffaroni N. Maciejewska N, et al. Among authors: baginski m. Cell Death Dis. 2022 Nov 28;13(11):1005. doi: 10.1038/s41419-022-05443-y. Cell Death Dis. 2022. PMID: 36437244 Free PMC article.

8

Modified Peptide Molecules As Potential Modulators of Shelterin Protein Functions; TRF1.

Brankiewicz W, Kalathiya U, Padariya M, Węgrzyn K, Prusinowski M, Zebrowska J, Zylicz-Stachula A, Skowron P, Drab M, Szajewski M, Ciesielski M, Gawrońska M, Kallingal A, Makowski M, Bagiński M. Brankiewicz W, et al. Among authors: baginski m. Chemistry. 2023 Oct 2;29(55):e202300970. doi: 10.1002/chem.202300970. Epub 2023 Sep 4. Chemistry. 2023. PMID: 37332024

9

Novel anticancer strategy aimed at targeting shelterin complexes by the induction of structural changes in telomeric DNA: hitting two birds with one stone.

Bidzinska J, Baginski M, Skladanowski A. Bidzinska J, et al. Among authors: baginski m. Curr Cancer Drug Targets. 2014;14(2):201-16. doi: 10.2174/1568009614666140120122535. Curr Cancer Drug Targets. 2014. PMID: 24443969 Review.

10

Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer.

Maciejewska N, Olszewski M, Jurasz J, Serocki M, Dzierzynska M, Cekala K, Wieczerzak E, Baginski M. Maciejewska N, et al. Among authors: baginski m. Sci Rep. 2022 Mar 8;12(1):3703. doi: 10.1038/s41598-022-07691-6. Sci Rep. 2022. PMID: 35260633 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year